Skip to main content
. Author manuscript; available in PMC: 2015 May 3.
Published in final edited form as: BMB Rep. 2008 Dec 31;41(12):833–839. doi: 10.5483/bmbrep.2008.41.12.833

Table 1.

Antagonists of HGF and c-Met binding

Group Compound Developmental
stage
References
HGF/c-Met antagonists NK4 Preclinical (57, 58)
Uncleavable HGF Preclinical (59)
Sema Preclinical (60)
Decoy Met Preclinical (61)
Recombinant variant Met Preclinical (62)

Antibodies against HGF L2G7 (Galaxy Biotech) Preclinical (63)
AMG102 (Amgen) Phase II (64)

Antibodies against HGF OA-5D5 (Genentech) Preclinical (65)
CE-355621 (Pfizer) Preclinical (66)
DN30 (Metheresis) Preclinical (67)